Today's signals · No active technical signal.
Signal details →Relmada Therapeutics last closed at $3.28 (-5.75%) on 2026-10-06. Listed on Nasdaq. Trailing 12 months PER is -6.0×. Its overall grade ranks 252 of 740 stocks in Healthcare.
About this company
Relmada Therapeutics last closed at $3.28 (-5.75%) on 2026-10-06. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B+ · 252/740
Valuation grade A
Related stocks
- AbbVieCompetitor
통증·중추신경계 치료제 개발 분야에서 대형 제약사로 경쟁 가능성이 큼
- PfizerCompetitor
신경계·희귀질환 포함 대형 바이오/제약사로 관련 치료제 시장에서 경쟁
- Johnson & JohnsonCompetitor
글로벌 제약사로 CNS 및 진통제 관련 시장에서 경쟁 상대
ETFs holding this stock
AdvisorShares Psychedelics ETF
Details →About Relmada Therapeutics
- What technical signals does Relmada Therapeutics (RLMD) have?
- Relmada Therapeutics current technical signals: no active technical signal.
- Is Relmada Therapeutics a cup-and-handle pattern?
- No. Relmada Therapeutics has no valid Cup signal right now.
- What published figures are available for Relmada Therapeutics?
- Market cap: $240.53M. Trailing 12 months PER: -6.0×. Latest quarter PBR: 1.78×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Relmada Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.